Multiple sclerosis
Conditions
Interventions
Addition of ramatroban to conventional MS therapy
Sponsors
Iou hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Non-responder to the conventional therapy in multiple sclerosis patients
Exclusion criteria
Exclusion criteria: pregnant woman
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Suppression of the new lesion in the brain MRI | — |
Countries
Japan
Outcome results
None listed